Nucleic acids encoding parathyroid hormone (PTH) derivatives

Details Nucleic acids encoding parathyroid hormone (PTH) derivatives Nucleic acids encoding parathyroid hormone (PTH) derivatives

2008-05-13

2008-05-13

Weber, Jon (Department: 1656)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C435S069100, C435S320100, C435S252300, C435S325000

Reexamination Certificate

active

07371844

ABSTRACT:
Parathyroid hormone(PTH) polypeptide derivatives are disclosed, as are pharmaceutical compositions containing said polypeptides, and synthetic and recombinant methods for producing said polypeptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said polypeptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.

REFERENCES:
patent: 4086196 (1978-04-01), Tregear
patent: 4698328 (1987-10-01), Neer et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4761406 (1988-08-01), Flora et al.
patent: 5393869 (1995-02-01), Nakagawa et al.
patent: 5501979 (1996-03-01), Geller et al.
patent: 5656465 (1997-08-01), Panicali et al.
patent: 5693616 (1997-12-01), Krstenansky et al.
patent: 5723577 (1998-03-01), Dong
patent: 5741486 (1998-04-01), Pathak et al.
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5836905 (1998-11-01), Lemelson et al.
patent: 5917123 (1999-06-01), McTiernan et al.
patent: 5922927 (1999-07-01), Bujard et al.
patent: 0 477 885 (1992-04-01), None
patent: 0 561 412 (1993-09-01), None
patent: 0 748 817 (1996-12-01), None
patent: WO 92/17581 (1992-10-01), None
patent: WO 95/11988 (1995-05-01), None
patent: WO 97/02834 (1997-01-01), None
patent: WO 00/31266 (2000-06-01), None
Heinrich et al. “Gene encoding parathyroid hormone,” J. of Biol. Chem., vol. 259, No. 5, pp. 3320-3329, Mar. 10, 1984.
Heinrich et al. “Rat parathyroid hormone gene, exons II and III,” Alignment result 8, SEQ ID No. 1, Database: GenEmbl, Accession No. K01268, Apr. 27, 1993.
Altschul, S.F., et al., “Basic Local Alignment Search Tool,”J. Mol. Biol. 215:403-410, Academic Press (1990).
Azarani, A., et al., “Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na +/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways,”J. Biol. Chem. 271:14931-14936, American Society for Biochemistry and Molecular Biology (1996).
Barbier, J.-R., et al., “Bioactivities and Secondary Structures of Constrained Analogues of Human Parathyroid Hormone: Cyclic Lactams of the Receptor Binding Region,”J. Med. Chem. 40:1373-1380, The American Chemical Society (1997).
Bisello, A., et al., “Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies,”J. Biol. Chem. 273:22498-22505, American Society for Biochemistry and Molecular Biology (Aug. 1998).
Born, W., et al., “Inhibition of Parathyroid Hormone Bioactivity by Human Parathyroid Hormone (PTH)-(3-84) and PTH-(8-84) Synthesized inEscherichia coli, ” Endocrinol. 123:1848-1853, The Endocrine Society (1988).
Broadus, A.E., and Stewart, A.F., “Parathyroid Hormone-Related Protein: Structure, Processing and Physiological Actions,” inThe Parathyroids, Basic and Clinical Concepts, Bilezikian, J.P., et al., eds., Raven Press, N.Y., pp. 259-294 (1994).
Caulfield, M.P., et al., “The Bovine Renal Parathyroid Hormone (PTH) Receptor Has Equal Affinity for Two Different Amino Acid Sequences: The Receptor Binding Domains of PTH and PTH-Related Protein Are Located within the 14-34 Region,”Endocrinol. 127:83-87, The Endocrine Society (1990).
Cenatiempo, Y., “Prokaryotic gene expression in vitro transcription—translation coupled systems,”Biochimie 68:505-515, Elsevier (1986).
Chorev, M., et al., “Modifications of Position 12 in Parathyroid Hormone and Parathyroid Hormone Related Protein: Toward the Design of Highly Potent Antagonists,”Biochem. 29:1580-1586, The American Chemical Society (1990).
Cohen, F.E., et al., “Analogues of Parathyroid Hormone Modified at Positions 3 and 6,”J. Biol. Chem. 266:1997-2004, American Society for Biochemistry and Molecular Biology (1991).
Cwirla, S. E., et al., “Peptide Agonist of the Thrombopoetin Receptor as Potent as the Natural Cytokine,”Science 276:1696-1699, American Association for the Advancement of Science (1997).
Dong, M., et al., “Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling,”J. Biol. Chem. 274:903-909, American Society for Biochemistry and Molecular Biology (Jan. 1999).
Fairwell, T., et al., “Total Solid-Phase Synthesis, Purification, and Characterization of Human Parathyroid Hormone-(1-84),”Biochem. 22:2691-2697, The American Chemical Society (1983).
Gardella, T.J., et al., “Expression of Human Parathyroid Hormone-(1-84) inEscherichia colias a Factor X-cleavable Fusion Protein,”J. Biol. Chem. 265:15854-15859, American Society for Biochemistry and Molecular Biology (1990).
Gardella, T.J., et al., “Mutational Analysis of the Receptor-activating Region of Human Parathyroid Hormone,”J. Biol. Chem. 266:13141-13146, American Society for Biochemistry and Molecular Biology (1991).
Gardella, T.J., et al., “Analysis of Parathyroid Hormone's Principal Receptor-Binding Region by Site-Directed Mutagenesis and Analog Design,”Endocrinol. 132:2024-2030, The Endocrine Society (1993).
Gardella, T.J., et al., “Parathyroid Hormone (PTH)-PTH-related Peptide Hybrid Peptides Reveal Functional Interations between 1-14 and 15-34 Domains of the Ligand,”J. Biol. Chem. 270:6584-6588, American Society for Biochemistry and Molecular Biology (1995).
Goltzmann, D., et al., “Analysis of the Requirements for Parathyroid Hormone Action in Renal Membranes with the Use of Inhibiting Analogues,”J. Biol. Chem. 250:3199-3203, American Society for Biochemistry and Molecular Biology (1975).
Gombert, F.O., et al., “Alanine and D-Amino Acid Scan of Human Parathyroid Hormone,” inPeptides: Chemistry, Structure and Biology, Kaumaya, P.T.P. and Hodges, R.S., eds., Mayflower Scientific Ltd., England, UK, pp. 661-662 (1996).
Gottesman, S., “Bacterial Regulation: Global Regulatory Networks,”Ann. Rev. Genet. 18:415-441, Annual Reviews, Inc. (1984).
Goud, N.A., et al., Solid-Phase Synthesis and Biologic Activity of Human Parathyroid Hormone(1-84),J. Bone Min. Res. 6:781-789, Mary Ann Liebert, Inc. (1991).
Hoare, S.R.J., et al., “Measurement of Agonist and Antagonist Ligand-Binding Parameters at the Human Parathyroid Hormone Type 1 Receptor: Evaluation of Receptor States and Modulation by Guanine Nucleotide,”J. Pharmacol. Exp. Ther. 289:1323-1333, American Society for Pharmacology and Experimental Therapeutics (Jun. 1999).
Holtmann, M.H., et al., “Critical Contributions of Amino-terminal Extracellular Domains in Agonist Biding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors,”J. Biol. Chem. 270:14394-14398, American Society for Biochemistry and Molecular Biology (1995).
Holtmann, M. H., et al., “Molecular Basis and Species Specificity of High Affinity Binding of Vasoactive Intestinal Polypeptide by the Rat Secretin Receptor,”J. Pharmacol. Exp. Ther. 279:555-560, American Society for Pharmacology and Experimental Therapeutics (1996).
Horiuchi, N., et al., “A Parathyroid Hormone Inhibitor in vivo: Design and Biological Evaluation of a Hormone Analog,”Science 220:1053-1055, American Association for the Advancement of Science (1983).
Izaki, K., “Plasmid Induced Heavy Metal Resistance in Bacteria,”Jpn. J. Bacteriol. 33:729-742, Japanese Society for Bacteriology (1978) [in Japanese].
John, Jr., J.F., and Twitty, J.A., “Plasmids as Epidemiologic Markers in Nosocomial Gram-Negative Bacilli: Experience at a University and Review of the Literature,”Rev. Infect. Dis. 8:693-704, The Universi

Affiliated with

Also associated with

Rating

Nucleic acids encoding parathyroid hormone (PTH) derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids encoding parathyroid hormone (PTH) derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding parathyroid hormone (PTH) derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2815265